Table 2. Laboratory findings of patients in the Shanghai cohort at admission.
| Early-start group (n = 47) |
Control group (n = 21) |
P value | |
|---|---|---|---|
| Blood routine and lymphocyte classification | |||
| White blood count, ×109/L | 4.6 ± 1.6 | 5.2 ± 1.8 | 0.199 |
| Neutrophils, ×109/L | 3.3 ± 1.6 | 3.7 ± 1.1 | 0.452 |
| Lymphocytes, ×109/L | 0.89 ± 0.3 | 1.0 ± 1.1 | 0.671 |
| CD4 positive cell, cell/µL | 312.3 ± 161.1 | 239.8 ± 156.3 | 0.132 |
| CD8 positive cell, cell/µL | 193.4 ± 102.0 | 367.6 ± 868.6 | 0.348 |
| Haemoglobin, g/L | 134.7 ± 14.8 | 134.5 ± 17.9 | 0.976 |
| Platelets, ×109/L | 160.4 ± 55.0 | 148.0 ± 32.7 | 0.343 |
| Blood biochemistry | |||
| Alanine aminotransferase, U/L | 29.4 ± 20.5 | 36.4 ± 24.1 | 0.223 |
| Aspartate aminotransferase, U/L | 33.5 ± 15.3 | 41.6 ± 22.5 | 0.087 |
| Albumin, g/L | 38.6 ± 4.2 | 38.4 ± 3.6 | 0.852 |
| Creatine, μmol/L | 76.1 ± 34.8 | 72.6 ± 19.7 | 0.678 |
| eGFR, mL/(min×1.73 m2) | 103.7 ± 29.1 | 97.6 ± 19.3 | 0.384 |
| Creatine kinase, U/L | 195.1 ± 233.5 | 328.9 ± 627.7 | 0.365 |
| Troponin T, ng/mL | 0.036 ± 0.037 | 0.042 ± 0.036 | 0.620 |
| Lactate dehydrogenase, U/L | 289.3 ± 78.9 | 323.9 ± 92.1 | 0.117 |
| NT-proBNP, pg/mL | 163.5 ± 359.7 | 208.1 ± 475.1 | 0.671 |
| Coagulation function | |||
| Prothrombin time, s | 13.4 ± 0.60 | 13.7 ± 1.18 | 0.187 |
| APTT, s | 41.5 ± 4.2 | 45.2 ± 8.6 | 0.069 |
| FDP, μg/mL | 2.1 ± 3.9 | 1.60 ± 1.38 | 0.570 |
| d-dimer, μg/mL | 1.25 ± 2.98 | 0.77 ± 0.54 | 0.465 |
| Infection-related parameters | |||
| C-reactive protein, mg/L | 35.8 ± 38.0 | 38.8 ± 28.7 | 0.931 |
| Procalcitonin, ng/mL | 0.10 ± 0.33 | 0.13 ± 0.14 | 0.941 |
| ESR, mm/h | 65.4 ± 38.9 | 57.1 ± 32.2 | 0.258 |
Notes: Data are shown as mean ± standard deviation. APTT, Activated partial thromboplastin time; eGFR, estimated glomerular filtration rate; ESR, erythrocyte sedimentation rate; FDP, Fibrinogen degradation products; NT-proBNP, N-terminal pro-B-type natriuretic peptide.